TY - JOUR T1 - Alcov: Estimating Variant of Concern Abundance from SARS-CoV-2 Wastewater Sequencing Data JF - medRxiv DO - 10.1101/2021.06.03.21258306 SP - 2021.06.03.21258306 AU - Isaac Ellmen AU - Michael D.J. Lynch AU - Delaney Nash AU - Jiujun Cheng AU - Jozef I. Nissimov AU - Trevor C. Charles Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/06/2021.06.03.21258306.abstract N2 - Detection of SARS-CoV-2 in wastewater is an important strategy for community level surveillance. Variants of concern (VOCs) can be detected in the wastewater samples using next generation sequencing, however it can be challenging to determine the relative abundance of different VOCs since the reads cannot be assembled into complete genomes. Here, we present Alcov (abundance learning of SARS-CoV-2 variants), a tool that uses mutation frequencies in SARS-CoV-2 sequencing data to predict the distribution of VOC lineages in the sample. We used Alcov to predict the distributions of lineages from three wastewater samples which agreed well with clinical data. By predicting not just which VOCs are present, but their relative abundances in the population, Alcov extracts a more complete snapshot of the variants which are circulating in a community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Mitacs Accelerate Fellowships (IT18981) to IE and DN, through funding held by JIN.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight body was necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData IDs which are used are provided. Source code is linked. https://github.com/Ellmen/alcov ER -